Lung Cancer News

In this video, Andrew Ciupek, PhD, spoke with Healio about non-treatment-related presentations from at the World Conference on Lung Cancer.

In this video, Andrew Ciupek, PhD, discusses findings from the Alliance trial, IMpower010 and NADIM-2.

Immune checkpoint inhibitor therapy appeared associated with an increased risk for major adverse cardiovascular events among patients with cancer and a prior history of cardiovascular disease, according to results of a retrospective study.

Andrew Ciupek, PhD, spoke with Healio about real-world barriers to clinical trial enrollment for patients with lung cancer in the United States.

Electronic noses that detect volatile organic compounds in exhaled breath have emerged as potential tools for cancer detection, but more investigation is needed before they can become part of the diagnostic workup, according to researchers.

Before the opening of City of Hope’s new comprehensive cancer center, many residents of Orange County, California, faced a long commute for advanced cancer care.

Sotorasib prolonged PFS compared with standard chemotherapy for certain patients with non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

Well-educated, white patients with cancer used medical aid in dying more than any other demographic, according to a study published in Journal of the American Geriatrics Society.

Submitted medical claims and out-of-pocket costs for genetic counseling encounters appeared relatively low among patients with certain cancer types, according to a research letter published in JAMA Health Forum.

Narjust Florez (Duma), MD, discusses results from two studies presented at World Conference on Lung Cancer — IMpower010 and NADIM-2